Circulating biomarkers for prostate cancer
T Steuber, P Helo, H Lilja - World journal of urology, 2007 - Springer
Due to its significant applicability for early detection, risk prediction and follow-up evaluation,
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
Circulating biomarkers for prostate cancer
T Steuber, P Helo, H Lilja - World Journal of Urology, 2007 - infona.pl
Due to its significant applicability for early detection, risk prediction and follow-up evaluation,
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
Circulating biomarkers for prostate cancer
T Steuber, P Helo, H Lilja - World Journal of Urology, 2007 - lup.lub.lu.se
Due to its significant applicability for early detection, risk prediction and follow-up evaluation,
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
[引用][C] Circulating biomarkers for prostate cancer
T STEUBER, P HELO, H LILJA - World journal of urology (Print …, 2007 - pascal-francis.inist.fr
Circulating biomarkers for prostate cancer CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Circulating biomarkers for prostate cancer
T Steuber, P Helo, H Lilja - World Journal of Urology, 2007 - portal.research.lu.se
Due to its significant applicability for early detection, risk prediction and follow-up evaluation,
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
Circulating biomarkers for prostate cancer.
T Steuber, P Helo, H Lilja - World Journal of Urology, 2007 - search.ebscohost.com
Due to its significant applicability for early detection, risk prediction and follow-up evaluation,
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
Circulating biomarkers for prostate cancer.
T Steuber, P Helo, H Lilja - World Journal of Urology, 2007 - europepmc.org
Due to its significant applicability for early detection, risk prediction and follow-up evaluation,
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
Circulating biomarkers for prostate cancer
T Steuber, P Helo, H Lilja - World journal of urology, 2007 - pubmed.ncbi.nlm.nih.gov
Due to its significant applicability for early detection, risk prediction and follow-up evaluation,
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
Circulating biomarkers for prostate cancer
T Steuber, P Helo, H Lilja - World Journal of Urology, 2007 - search.proquest.com
Due to its significant applicability for early detection, risk prediction and follow-up evaluation,
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
Circulating biomarkers for prostate cancer.
T Steuber, P Helo, H Lilja - World journal of urology, 2007 - ora.ox.ac.uk
Due to its significant applicability for early detection, risk prediction and follow-up evaluation,
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …